Brief: Biovaxys Says Co And Horizon Technology Finance Corp Execute Amendment To Asset Purchase Agreement
30/05/2025 01:42
May 29 (Reuters) - Biovaxys Technology Corp BIOV.CD:
BIOVAXYS AND HORIZON TECHNOLOGY FINANCE CORP EXECUTE AMENDMENT TO ASSET PURCHASE AGREEMENT ("APA")
BIOVAXYS TECHNOLOGY CORP - NEW AMENDMENT LOWERS CAPITAL RAISE MILESTONE TO $2,028,636
Source text: ID:nCNWlyFRSa
Further company coverage: BIOV.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biovaxys Technology
See all newsBrief: Biovaxys Appoints Former Sanofi Vaccines Executive To Board Of Directors
Brief: Biovaxys Announces Life Offering
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys And Horizon Technology Finance Execute Amendment To Asset Purchase Agreement
Brief: Biovaxys Announces Consolidation And Concurrent Brokered Private Placement Offering For Gross Proceeds Of Up To $3,000,000